Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.01%189.88B | -4.65%48.82B | 7.02%197.82B | -2.49%46.37B | 5.62%52.55B | 5.41%47.7B | 21.08%51.2B | 15.48%184.84B | -3.44%47.56B | 40.99%49.75B |
| Cost of revenue | -3.10%164.13B | -5.16%41.78B | 7.79%169.38B | 1.15%40.36B | 5.14%44.14B | 4.62%40.82B | 21.59%44.05B | 17.03%157.13B | -2.81%39.9B | 41.28%41.98B |
| Gross profit | -9.43%25.76B | -1.47%7.04B | 2.63%28.44B | -21.49%6.01B | 8.20%8.41B | 10.31%6.88B | 18.09%7.15B | 7.44%27.71B | -6.65%7.65B | 39.44%7.77B |
| Operating expense | 3.06%16.11B | 3.98%3.98B | 7.07%15.63B | 13.41%4.03B | 4.15%3.94B | 4.94%3.85B | 6.05%3.82B | 9.22%14.6B | -5.94%3.55B | 24.18%3.78B |
| Operating profit | -24.69%9.65B | -7.73%3.07B | -2.30%12.81B | -51.67%1.98B | 12.04%4.47B | 17.98%3.03B | 35.83%3.33B | 5.52%13.11B | -7.25%4.11B | 57.82%3.99B |
| Net non-operating interest income (expenses) | 22.80%-193M | 32.89%-51M | -5.04%-250M | 79.71%-14M | 12.82%-68M | -84.00%-92M | -85.37%-76M | -78.95%-238M | -68.29%-69M | -151.61%-78M |
| Non-operating interest income | 31.47%188M | 213.33%47M | 472.00%143M | 671.43%54M | 400.00%50M | 500.00%24M | 275.00%15M | 0.00%25M | -12.50%7M | 66.67%10M |
| Non-operating interest expense | -3.05%381M | 7.69%98M | 49.43%393M | -10.53%68M | 34.09%118M | 114.81%116M | 102.22%91M | 66.46%263M | 55.10%76M | 137.84%88M |
| Net investment income | -6.83%723M | -13.01%361M | 4.44%776M | 662.50%61M | 1,230.77%147M | -34.62%153M | -19.26%415M | 134.38%743M | -97.89%8M | 50.00%-13M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -63.42%169M | 38M | 462M | 200.00%462M | 0 | 0 | 154M | -107.32%-3M | ||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -199.10%-219M | -97.38%13M | 125.09%221M | -722.92%-299M | 100.49%9M | -98.31%15M | 16,433.33%496M | 8.70%-881M | 125.53%48M | -142.48%-1.82B |
| Less:Other special charges | 116.59%74M | 97.38%-13M | 53.93%-446M | -11.90%74M | 94.38%-9M | 98.31%-15M | -16,433.33%-496M | -216.91%-968M | 64.71%84M | -121.30%-160M |
| Less:Write off | -35.56%145M | ---- | -87.83%225M | 270.45%225M | --0 | ---- | ---- | 1,249.64%1.85B | -196.35%-132M | ---- |
| Other non-operating income (expenses) | -18.25%103M | 21.74%28M | 28.57%126M | -40.74%16M | -73.17%11M | 322.22%76M | 91.67%23M | 53.13%98M | 237.50%27M | 192.86%41M |
| Income before tax | -27.68%10.23B | -17.40%3.46B | 10.22%14.15B | -48.28%2.21B | 115.99%4.57B | -9.21%3.18B | 42.44%4.19B | 9.24%12.83B | -6.74%4.28B | 19.23%2.11B |
| Income tax | -22.07%2.82B | -41.74%624M | 8.03%3.62B | -43.84%456M | 29.65%1.3B | -11.93%790M | 68.13%1.07B | 44.13%3.35B | 7.27%812M | 48.23%1.01B |
| Net income | -29.61%7.41B | -8.99%2.83B | 10.99%10.52B | -49.32%1.76B | 194.23%3.26B | -8.31%2.39B | 35.35%3.11B | 0.65%9.48B | -9.51%3.46B | 1.28%1.11B |
| Net income continuous operations | -29.62%7.41B | -9.02%2.83B | 11.00%10.53B | -49.32%1.76B | 194.23%3.26B | -8.28%2.39B | 35.33%3.11B | 0.64%9.48B | -9.51%3.46B | 1.28%1.11B |
| Noncontrolling interests | -45.73%1.33B | -15.52%615M | -9.07%2.45B | -48.73%424M | 5.89%935M | 16.61%358M | 8.33%728M | 16.21%2.69B | 8.10%827M | 148.03%883M |
| Net income attributable to the company | -24.73%6.08B | -6.96%2.22B | 18.92%8.08B | -49.56%1.33B | 930.09%2.33B | -11.56%2.04B | 46.44%2.38B | -4.42%6.79B | -13.88%2.64B | -69.42%226M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -24.73%6.08B | -6.96%2.22B | 18.92%8.08B | -49.56%1.33B | 930.09%2.33B | -11.56%2.04B | 46.44%2.38B | -4.42%6.79B | -13.88%2.64B | -69.42%226M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -23.20%60.99 | -5.41%22.03 | 21.16%79.41 | -48.45%13.14 | 901.31%22.93 | -9.81%20.05 | 49.97%23.29 | -0.95%65.54 | -11.25%25.49 | -67.05%2.29 |
| Diluted earnings per share | -23.20%60.99 | -5.41%22.03 | 21.16%79.41 | -48.56%13.1122 | 946.22%22.93 | -9.81%20.05 | 49.97%23.29 | -0.95%65.54 | -11.25%25.49 | -68.46%2.1917 |
| Dividend per share | 3.85%27 | 0 | 23.81%26 | 23.81%13 | 0 | 23.81%13 | 0 | 5.00%21 | 0.00%10.5 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |